Skip to main content
Top
Published in: Virchows Archiv 3/2016

01-09-2016 | Original Article

Total intraglandular and index tumor volumes predict biochemical recurrence in prostate cancer

Authors: Su-Jin Shin, Cheol Keun Park, Sung Yoon Park, Won Sik Jang, Joo Yong Lee, Young Deuk Choi, Nam Hoon Cho

Published in: Virchows Archiv | Issue 3/2016

Login to get access

Abstract

Prognostic value of tumor volume for biochemical recurrence of prostate cancer remains controversial. We aimed to determine which tumor volume definition would optimally correlate with established prognostic factors and classify macroscopic tumor configuration. Radical prostatectomy specimens with follow-up to biochemical recurrence in the period between 2009 and 2012 were retrieved. Newly proposed categories of reconstructed three-dimensional macroscopic tumor configuration were nodular, medial prominence, subcapsular spreading, and miliary types. Several algorithms were applied to identify optimal tumor volume including (1) combined volume of all nodules, (2) volume of largest nodule as index tumor, and (3) volume of nodule with strongest evidence of poor prognosis. Macroscopic typing correlated well with radiologic findings, and nodular type was most common (70.7 %). In most multifocal tumors, the largest nodule showed the highest Gleason score (90.8 %) as well as extraprostatic extension or seminal vesicle invasion (93.5 %). Total tumor and index tumor volumes were significant predictors of biochemical recurrence (both, P < 0.0001). Tumor volume, classified in three groups with cutoff values at 2 and 5 cm3, was independently predictive of recurrence-free survival in multivariate analysis (P < 0.05) and surpassed bilaterality even in stage pT2. In pT2 disease, recurrence-free survival was significantly associated with total tumor volume (P = 0.003) and index tumor volume (P = 0.002), but not with pT2 substage (P = 0.278). The proposed macroscopic classification system can be correlated with preoperative imaging findings. Total tumor or index tumor volume significantly predicts biochemical recurrence. Tumor volume classification is easy to apply in practice with high reproducibility and offsets the limitations of pT classification.
Appendix
Available only for authorised users
Literature
3.
go back to reference McNeal JE, Price HM, Redwine EA, Freiha FS, Stamey TA (1988) Stage a versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance. J Urol 139(1):61–65PubMed McNeal JE, Price HM, Redwine EA, Freiha FS, Stamey TA (1988) Stage a versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance. J Urol 139(1):61–65PubMed
4.
go back to reference Santoni M, Scarpelli M, Mazzucchelli R, Lopez-Beltran A, Cheng L, Epstein JI, Cascinu S, Briganti A, Catto JW, Montorsi F, Montironi R (2016) Current histopathologic and molecular characterisations of prostate cancer: towards individualised prognosis and therapies. Eur Urol 69(2):186–190. doi:10.1016/j.eururo.2015.05.041 CrossRefPubMed Santoni M, Scarpelli M, Mazzucchelli R, Lopez-Beltran A, Cheng L, Epstein JI, Cascinu S, Briganti A, Catto JW, Montorsi F, Montironi R (2016) Current histopathologic and molecular characterisations of prostate cancer: towards individualised prognosis and therapies. Eur Urol 69(2):186–190. doi:10.​1016/​j.​eururo.​2015.​05.​041 CrossRefPubMed
5.
go back to reference Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL, Committee IG (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29(9):1228–1242CrossRefPubMed Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL, Committee IG (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29(9):1228–1242CrossRefPubMed
6.
go back to reference van der Kwast TH, Amin MB, Billis A, Epstein JI, Griffiths D, Humphrey PA, Montironi R, Wheeler TM, Srigley JR, Egevad L, Delahunt B, Group IPC (2011) International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 24(1):16–25. doi:10.1038/modpathol.2010.156 CrossRefPubMed van der Kwast TH, Amin MB, Billis A, Epstein JI, Griffiths D, Humphrey PA, Montironi R, Wheeler TM, Srigley JR, Egevad L, Delahunt B, Group IPC (2011) International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 24(1):16–25. doi:10.​1038/​modpathol.​2010.​156 CrossRefPubMed
7.
go back to reference Ramos CG, Roehl KA, Antenor JA, Humphrey PA, Catalona WJ (2004) Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. J Urol 172(1):137–140. doi:10.1097/01.ju.0000132139.40964.75 CrossRefPubMed Ramos CG, Roehl KA, Antenor JA, Humphrey PA, Catalona WJ (2004) Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. J Urol 172(1):137–140. doi:10.​1097/​01.​ju.​0000132139.​40964.​75 CrossRefPubMed
8.
go back to reference Eichelberger LE, Koch MO, Eble JN, Ulbright TM, Juliar BE, Cheng L (2005) Maximum tumor diameter is an independent predictor of prostate-specific antigen recurrence in prostate cancer. Mod Pathol 18(7):886–890. doi:10.1038/modpathol.3800405 CrossRefPubMed Eichelberger LE, Koch MO, Eble JN, Ulbright TM, Juliar BE, Cheng L (2005) Maximum tumor diameter is an independent predictor of prostate-specific antigen recurrence in prostate cancer. Mod Pathol 18(7):886–890. doi:10.​1038/​modpathol.​3800405 CrossRefPubMed
9.
go back to reference Chun FK, Briganti A, Jeldres C, Gallina A, Erbersdobler A, Schlomm T, Walz J, Eichelberg C, Salomon G, Haese A, Currlin E, Ahyai SA, Benard F, Huland H, Graefen M, Karakiewicz PI (2007) Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Eur J Cancer 43(3):536–543. doi:10.1016/j.ejca.2006.10.018 CrossRefPubMed Chun FK, Briganti A, Jeldres C, Gallina A, Erbersdobler A, Schlomm T, Walz J, Eichelberg C, Salomon G, Haese A, Currlin E, Ahyai SA, Benard F, Huland H, Graefen M, Karakiewicz PI (2007) Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Eur J Cancer 43(3):536–543. doi:10.​1016/​j.​ejca.​2006.​10.​018 CrossRefPubMed
10.
go back to reference Salomon L, Levrel O, Anastasiadis AG, Irani J, De La Taille A, Saint F, Vordos D, Cicco A, Hoznek A, Chopin D, Abbou CC (2003) Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factors. Eur Urol 43(1):39–44CrossRefPubMed Salomon L, Levrel O, Anastasiadis AG, Irani J, De La Taille A, Saint F, Vordos D, Cicco A, Hoznek A, Chopin D, Abbou CC (2003) Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factors. Eur Urol 43(1):39–44CrossRefPubMed
12.
go back to reference Wolters T, Roobol MJ, van Leeuwen PJ, van den Bergh RC, Hoedemaeker RF, van Leenders GJ, Schroder FH, van der Kwast TH (2010) Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer. Eur Urol 57(5):821–829. doi:10.1016/j.eururo.2009.07.027 CrossRefPubMed Wolters T, Roobol MJ, van Leeuwen PJ, van den Bergh RC, Hoedemaeker RF, van Leenders GJ, Schroder FH, van der Kwast TH (2010) Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer. Eur Urol 57(5):821–829. doi:10.​1016/​j.​eururo.​2009.​07.​027 CrossRefPubMed
15.
go back to reference Huang CC, Deng FM, Kong MX, Ren Q, Melamed J, Zhou M (2014) Re-evaluating the concept of “dominant/index tumor nodule” in multifocal prostate cancer. Virchows Archiv: an International Journal of Pathology 464(5):589–594. doi:10.1007/s00428-014-1557-y CrossRef Huang CC, Deng FM, Kong MX, Ren Q, Melamed J, Zhou M (2014) Re-evaluating the concept of “dominant/index tumor nodule” in multifocal prostate cancer. Virchows Archiv: an International Journal of Pathology 464(5):589–594. doi:10.​1007/​s00428-014-1557-y CrossRef
16.
go back to reference Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P (2000) Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 89(8):1800–1809CrossRefPubMed Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P (2000) Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 89(8):1800–1809CrossRefPubMed
17.
go back to reference Scattoni V, Montironi R, Mazzucchelli R, Freschi M, Nava L, Losa A, Terrone C, Scarpa RM, Montorsi F, Pappagallo G, Rigatti P (2006) Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg. BJU Int 98(1):54–58. doi:10.1111/j.1464-410X.2006.06204.x CrossRefPubMed Scattoni V, Montironi R, Mazzucchelli R, Freschi M, Nava L, Losa A, Terrone C, Scarpa RM, Montorsi F, Pappagallo G, Rigatti P (2006) Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg. BJU Int 98(1):54–58. doi:10.​1111/​j.​1464-410X.​2006.​06204.​x CrossRefPubMed
18.
go back to reference Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA, Grading C (2016) The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol 40(2):244–252. doi:10.1097/PAS.0000000000000530 PubMed Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA, Grading C (2016) The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol 40(2):244–252. doi:10.​1097/​PAS.​0000000000000530​ PubMed
20.
go back to reference Hoeks CM, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SW, Scheenen TW, Vos PC, Huisman H, van Oort IM, Witjes JA, Heerschap A, Futterer JJ (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261(1):46–66. doi:10.1148/radiol.11091822 CrossRefPubMed Hoeks CM, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SW, Scheenen TW, Vos PC, Huisman H, van Oort IM, Witjes JA, Heerschap A, Futterer JJ (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261(1):46–66. doi:10.​1148/​radiol.​11091822 CrossRefPubMed
21.
go back to reference Verma S, Turkbey B, Muradyan N, Rajesh A, Cornud F, Haider MA, Choyke PL, Harisinghani M (2012) Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. AJR Am J Roentgenol 198(6):1277–1288. doi:10.2214/AJR.12.8510 CrossRefPubMed Verma S, Turkbey B, Muradyan N, Rajesh A, Cornud F, Haider MA, Choyke PL, Harisinghani M (2012) Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. AJR Am J Roentgenol 198(6):1277–1288. doi:10.​2214/​AJR.​12.​8510 CrossRefPubMed
22.
go back to reference Tamada T, Sone T, Jo Y, Yamamoto A, Yamashita T, Egashira N, Imai S, Fukunaga M (2008) Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 248(2):531–539. doi:10.1148/radiol.2482070157 CrossRefPubMed Tamada T, Sone T, Jo Y, Yamamoto A, Yamashita T, Egashira N, Imai S, Fukunaga M (2008) Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 248(2):531–539. doi:10.​1148/​radiol.​2482070157 CrossRefPubMed
24.
go back to reference Hansen J, Bianchi M, Sun M, Rink M, Castiglione F, Abdollah F, Steuber T, Ahyai SA, Steurer S, Gobel C, Freschi M, Montorsi F, Shariat SF, Fisch M, Graefen M, Karakiewicz PI, Briganti A, Chun FK (2014) Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score. BJU Int 113(3):399–407. doi:10.1111/bju.12424 CrossRefPubMed Hansen J, Bianchi M, Sun M, Rink M, Castiglione F, Abdollah F, Steuber T, Ahyai SA, Steurer S, Gobel C, Freschi M, Montorsi F, Shariat SF, Fisch M, Graefen M, Karakiewicz PI, Briganti A, Chun FK (2014) Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score. BJU Int 113(3):399–407. doi:10.​1111/​bju.​12424 CrossRefPubMed
25.
go back to reference Noguchi M, Stamey TA, McNeal JE, Yemoto CE (2000) Assessment of morphometric measurements of prostate carcinoma volume. Cancer 89(5):1056–1064CrossRefPubMed Noguchi M, Stamey TA, McNeal JE, Yemoto CE (2000) Assessment of morphometric measurements of prostate carcinoma volume. Cancer 89(5):1056–1064CrossRefPubMed
27.
28.
go back to reference Chen ME, Johnston D, Reyes AO, Soto CP, Babaian RJ, Troncoso P (2003) A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume. Am J Surg Pathol 27(10):1291–1301CrossRefPubMed Chen ME, Johnston D, Reyes AO, Soto CP, Babaian RJ, Troncoso P (2003) A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume. Am J Surg Pathol 27(10):1291–1301CrossRefPubMed
29.
go back to reference Wise AM, Stamey TA, McNeal JE, Clayton JL (2002) Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 60(2):264–269CrossRef Wise AM, Stamey TA, McNeal JE, Clayton JL (2002) Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 60(2):264–269CrossRef
32.
go back to reference Kordan Y, Chang SS, Salem S, Cookson MS, Clark PE, Davis R, Herrell SD, Baumgartner R, Phillips S, Smith JA Jr, Barocas DA (2009) Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy. J Urol 182(5):2291–2295. doi:10.1016/j.juro.2009.07.020 CrossRefPubMed Kordan Y, Chang SS, Salem S, Cookson MS, Clark PE, Davis R, Herrell SD, Baumgartner R, Phillips S, Smith JA Jr, Barocas DA (2009) Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy. J Urol 182(5):2291–2295. doi:10.​1016/​j.​juro.​2009.​07.​020 CrossRefPubMed
33.
go back to reference Chun FK, Briganti A, Lebeau T, Fradet V, Steuber T, Walz J, Schlomm T, Eichelberg C, Haese A, Erbersdobler A, McCormack M, Perrotte P, Graefen M, Huland H, Karakiewicz PI (2006) The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy. Eur Urol 49(2):273–278 . doi:10.1016/j.eururo.2005.12.009discussion 278-279CrossRefPubMed Chun FK, Briganti A, Lebeau T, Fradet V, Steuber T, Walz J, Schlomm T, Eichelberg C, Haese A, Erbersdobler A, McCormack M, Perrotte P, Graefen M, Huland H, Karakiewicz PI (2006) The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy. Eur Urol 49(2):273–278 . doi:10.​1016/​j.​eururo.​2005.​12.​009discussion 278-279CrossRefPubMed
35.
go back to reference Freedland SJ, Partin AW, Epstein JI, Walsh PC (2004) Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b. Cancer 100(8):1646–1649. doi:10.1002/cncr.20145 CrossRefPubMed Freedland SJ, Partin AW, Epstein JI, Walsh PC (2004) Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b. Cancer 100(8):1646–1649. doi:10.​1002/​cncr.​20145 CrossRefPubMed
Metadata
Title
Total intraglandular and index tumor volumes predict biochemical recurrence in prostate cancer
Authors
Su-Jin Shin
Cheol Keun Park
Sung Yoon Park
Won Sik Jang
Joo Yong Lee
Young Deuk Choi
Nam Hoon Cho
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
Virchows Archiv / Issue 3/2016
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-016-1971-4

Other articles of this Issue 3/2016

Virchows Archiv 3/2016 Go to the issue

Review and Perspectives

The spectrum of ectopic thymomas